NEW YORK (GenomeWeb News) – Cognia will add 50 jobs to its UK operations by the end of the year, the company said earlier this month.
 
New York-based Cognia opened a UK subsidiary with 10 employees in early 2005 as part of a three-year text-mining collaboration with the University of Edinburgh.
 
Cognia said that the program has “far exceeded” its expectations and that it plans to add a corporate service office in Cambridge, UK, with around 50 employees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.